Dr. Jain is a biotechnology industry veteran with more than two decades of experience in pharmaceutical development across her time with ChemoCentryx, AbbVie, Abbott Laboratories, and G.D. Searle and Co
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
The patent also covers the efficacy of the herbal composition in the management of metabolic syndrome disorders
LG Chem will receive totaling up to $95.5 million for the China rights
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Phase III trial also demonstrated a statistically significant reduction (14%) in hospitalization for any cause, bringing potential relief for patients and reducing burden on healthcare systems
Man lost 54 Kgs in 6 months with MGB procedure
Younger Indians have a 10 times higher rate of heart attack
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
Subscribe To Our Newsletter & Stay Updated
